Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

(2020) Chaomin Wu et al.   JAMA Internal Medicine

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

(2020) Jason Phua et al.   Lancet Respiratory Medicine

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection

(2019) Yeming Wang et al.   JOURNAL OF INFECTIOUS DISEASES

Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration

(2018) Chhinder P. Sodhi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Angioedema Due to Bradykinin Dysregulation

(2018) Marco Cicardi et al.   Journal of Allergy and Clinical Immunology-In Practice

Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema

(2017) Henriette Farkas et al.   Journal of Allergy and Clinical Immunology-In Practice

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate

(2015) B. L. Zuraw et al.   ALLERGY

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

(2009) Timothy J. Craig et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY